Literature DB >> 280711

Effect of chemotherapeutic agents on natural cell-mediated cytotoxicity in mice.

A Mantovani, W Luini, G Peri, A Vecchi, F Spreafico.   

Abstract

Spleen natural killer (NK) activity was investigated in cells from C57BL/6J mice treated with various chemotherapeutic agents; 51Cr-labeled YAC-1 lymphoma cells were used as targets. Treatment with azathioprine (a single injection of 100-400 mg/kg ip or 5 daily doses of 80 mg/kg lp) and cyclophosphamide (a single injection of 50--200 mg/kg ip or 5 daily doses of 25 mg/kg ip) resulted in a marked dose-dependent inhibition of NK activity 2 days later. NK cells recovered rapidly from drug-induced suppression; by 7 days after drug treatment, no difference from control values was observed. Dimethyltriazenoimidazole carboxamide (20--200 mg/kg ip) and adriamycin (10--15 mg/kg iv) did not impair natural cytotoxicity per unit number of lymphoid cells, daunomycin (10 mg/kg iv) caused borderline impairment of NK acitivity, and N-trifluoroacetyl-adriamycin-14-valerate (80 mg/kg iv) markedly suppressed natural cytotoxicity. These results are discussed in light of the known effects of these agents on T-cells, B-cells, and K-cells and on hematopoietic histocompatibility-type reactions.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 280711     DOI: 10.1093/jnci/61.5.1255

Source DB:  PubMed          Journal:  J Natl Cancer Inst        ISSN: 0027-8874            Impact factor:   13.506


  26 in total

1.  Response of natural killer cells from dietary tyrosine- and phenylalanine-restricted mice to biological response modifiers.

Authors:  G G Meadows; R M Abdallah; J R Starkey; C J Aslakson
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

2.  Cancer chemotherapeutics as immunomodulators.

Authors:  F Spreafico; A Vecchi; F Colotta; A Montovani
Journal:  Springer Semin Immunopathol       Date:  1985

3.  Investigation of the biological effects of anti-cell adhesive synthetic peptides that inhibit experimental metastasis of B16-F10 murine melanoma cells.

Authors:  M J Humphries; K M Yamada; K Olden
Journal:  J Clin Invest       Date:  1988-03       Impact factor: 14.808

4.  Improved therapeutic effects of interleukin 2 after the accumulation of lymphokine-activated killer cells in tumor tissue of mice previously treated with cyclophosphamide.

Authors:  M Hosokawa; Y Sawamura; T Morikage; F Okada; Z Y Xu; K Morikawa; K Itoh; H Kobayashi
Journal:  Cancer Immunol Immunother       Date:  1988       Impact factor: 6.968

5.  Loss of natural killer activity as an indicator of relapse in acute leukaemia.

Authors:  J A Tratkiewicz; J Szer
Journal:  Clin Exp Immunol       Date:  1990-05       Impact factor: 4.330

6.  Clearance of Giardia muris infection in mice deficient in natural killer cells.

Authors:  M F Heyworth; J E Kung; E C Eriksson
Journal:  Infect Immun       Date:  1986-12       Impact factor: 3.441

7.  Analysis of natural killer activity and antibody-dependent cellular cytotoxicity in healthy volunteers and in patients with primary lung cancer and metastatic pulmonary tumors.

Authors:  N Saijo; E Shimizu; N Irimajiri; A Ozaki; K Kimura; T Takizawa; H Niitani
Journal:  J Cancer Res Clin Oncol       Date:  1982       Impact factor: 4.553

8.  Chemotherapy-induced modulation of natural killer and lymphokine-activated killer cell activity in euthymic and athymic mice.

Authors:  Z Gazit; E Kedar
Journal:  Cancer Immunol Immunother       Date:  1994-04       Impact factor: 6.968

9.  Modulation of antitumoral antibody-dependent cellular cytotoxicity and natural killer activity by Adriamycin and daunorubicin.

Authors:  R W Pfeifer; H B Bosmann
Journal:  Agents Actions       Date:  1982-12

10.  Morphological characterization of a cell population responsible for natural killer activity.

Authors:  W Luini; D Boraschi; S Alberti; A Aleotti; A Tagliabue
Journal:  Immunology       Date:  1981-08       Impact factor: 7.397

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.